SIX Swiss Exchange · Healthcare
Invest in SKAN stock from India
Indian and foreign residents can buy SKAN (SKAN) shares directly through Paasa.
By Paasa · Updated
SKAN at a glance
- Price
- CHF 70.70+CHF 3.20 (4.74%)
- Market cap
- CHF 1.59B
- Day range
- CHF 68.30 – CHF 70.70
- P/E
- 53.16
- Dividend yield
- 0.31%
- Volume
- 119.66K
- 1 month
- +8.10%
- 6 months
- +72.44%
- YTD
- +33.90%
- 1 year
- +32.65%
- 5 years
- —
SKAN statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 333.3M | CHF 361.3M | CHF 320.0M | CHF 277.0M | CHF 234.3M |
| Gross profit | CHF 230.3M | CHF 265.9M | CHF 234.1M | CHF 200.5M | CHF 170.1M |
| Operating income | CHF 25.4M | CHF 44.5M | CHF 37.8M | CHF 29.5M | CHF 23.1M |
| Net income | CHF 16.3M | CHF 38.8M | CHF 26.3M | CHF 19.0M | CHF 10.6M |
| Earnings per share | CHF 0.72 | CHF 1.73 | CHF 1.17 | CHF 0.84 | CHF 0.84 |
| EBITDA | CHF 36.0M | CHF 59.7M | CHF 50.1M | CHF 40.2M | CHF 32.4M |
| Total assets | CHF 481.1M | CHF 384.5M | CHF 373.4M | CHF 388.4M | CHF 331.9M |
| Total debt | CHF 131.5M | CHF 10.6M | CHF 6.5M | CHF 16.9M | CHF 15.3M |
| Cash and short-term investments | CHF 94.1M | CHF 61.7M | CHF 85.1M | CHF 136.0M | CHF 131.5M |
| Shareholders' equity | CHF 114.4M | CHF 196.2M | CHF 169.2M | CHF 157.3M | CHF 159.7M |
| Operating cash flow | CHF 64.1M | CHF 46.7M | CHF 8.7M | CHF 61.5M | CHF 10.3M |
| Free cash flow | CHF 21.0M | −CHF 7.1M | −CHF 26.6M | CHF 32.6M | −CHF 32.3M |
| Capital expenditure | −CHF 43.1M | −CHF 53.8M | −CHF 35.3M | −CHF 28.9M | −CHF 42.6M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Tecan | TECN.SW | CHF 234.40 | CHF 2.97B |
| PolyPeptide | PPGN.SW | CHF 44.10 | CHF 1.46B |
| Aevis Victoria | AEVS.SW | CHF 15.75 | CHF 1.33B |
| Idorsia | IDIA.SW | CHF 4.65 | CHF 1.22B |
| Medartis | MED.SW | CHF 84.00 | CHF 1.05B |
| Cosmo Pharmaceuticals | COPN.SW | CHF 58.70 | CHF 1.01B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in SKAN from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search SKAN and buy
Find SKAN by name or by its ticker, SKAN, and place your order.
Why invest in SKAN from India
What SKAN does
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company operates through two distinct divisions: Equipment and Solutions (E&S), and Services and Consumables (S&C). SKAN operates in the Medical - Instruments & Supplies industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy SKAN stock from India?
Yes. Indian residents and NRIs can buy SKAN (SKAN) shares directly through Paasa. SKAN is listed on the SIX Swiss Exchange, in the Medical - Instruments & Supplies industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell SKAN shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.